Frontiers Safety and therapeutic effects of personalized

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial - The Lancet Infectious Diseases

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Extracellular vesicle-based biovectors in chronic wound healing: Biogenesis and delivery approaches: Molecular Therapy - Nucleic Acids

Telehealth and Patient Safety.

Presenting a sham treatment as personalised increases the placebo effect in a randomised controlled trial

Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine

Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases - ScienceDirect

Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec: Molecular Therapy - Methods & Clinical Development

Polypharmacy and precision medicine, Cambridge Prisms: Precision Medicine